Let’s open our eyes to the importance of vaginal microbiota. Correlation between dysbiosis and HPV infection: A review
DOI:
https://doi.org/10.12775/JEHS.2024.71.49399Keywords
Microbiota, Lactobacillus, Dysbiosis, Cervicovaginal microbiome, Human Papillomavirus, HPV, Cervical cancer, BacteriotherapyAbstract
Infections with the human papillomavirus (HPV) are one of the most common sexually transmitted diseases and are the main cause of precancerous changes and cervical cancer development. However, mere infection does not guarantee the development of disease or carcinogenesis. For this to occur, high-risk types of HPV must integrate into the host cell genome, transitioning into a persistent form of infection.
Following the discovery of risk factors for HPV infection and factors predisposing infection to a persistent form, the number of studies investigating the correlation between vaginal dysbiosis and infection has significantly increased. Numerous studies document a significant association between the state of vaginal bacterial flora and HPV infection, leading to the development of plentiful studies on infection pathogenesis, risk factors, prevention, and treatment methods using bacteria. In this paper, based on recently published studies and current state of science knowledge, we will outline the topic of vaginal microbiome, emphasize the importance of bacteria inhabiting the vagina for human health, and identify the problem of changes in vaginal microflora. We would like to contribute to the dissemination of knowledge about the vaginal microbiome and general knowledge about taking care of its health. We will also summarize available treatment methods based on bacterial environment and discuss those methods for which research is currently underway or should be initiated.
References
Sirota I, Zarek SM, Segars JH (2014) Potential infuence of the microbiome on infertility and assisted reproductive technology. Semin Reprod Med 32(1):35–42
Sobel JD (1999) Is There a protective role for vaginal fora? Curr Infect Dis Rep 1(4):379–383
Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, Koenig SS, Fu L, Ma ZS, Zhou X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132):132RA52 Temporal Dynamics of the Human Vaginal Microbiota | Science Translational Medicine
Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K, Winter C, Meier A, Stamm WE. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis. 2000;30(6):901–7.
MacIntyre DA, Chandiramani M, Lee YS, Kindinger L, Smith A, Angelopoulos N, Lehne B, Arulkumaran S, Brown R, Teoh TG, et al. The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci Rep. 2015;5:8988
Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014;21(5):450–8.
Vodstrcil LA, Hocking JS, Law M, Walker S, Tabrizi SN, Fairley CK, Bradshaw CS. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One. 2013;8(9):e73055.
Mandar R, Punab M, Borovkova N, Lapp E, Kiiker R, Korrovits P, Metspalu A, Krjutskov K, Nolvak H, Preem JK, et al. Complementary seminovaginal microbiome in couples. Res Microbiol. 2015;166(5):440–7.
Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UM, Zhong X et al (2012) Temporal dynamics of the human vaginal microbiota. Sci Transl Med. https://doi.org/10.1126/scitranslmed.3003605
DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A et al (2015) Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci USA 112(35):11060–11065
Huang Y, Merkatz RB, Hillier SL, Roberts K, Blithe DL, SitrukWare R et al (2015) efects of a one year reusable contraceptive vaginal ring on vaginal microfora and the risk of vaginal infection: an open-label prospective evaluation. PLoS ONE 10(8):e0134460
Water Aid. Menstrual hygiene matters. [http://www.wateraid.org/what-wedo/our-approach/research-and-publications/view-publication?id=02309d73- 8e41-4d04-b2ef-6641f6616a4f]. Accessed 19 Oct 2016.
Holzman C, Leventhal JM, Qiu H, Jones NM, Wang J, Group BS (2001) Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health 91(10):1664–1670
Smart S, Singal A, Mindel A (2004) Social and sexual risk factors for bacterial vaginosis. Sex Transm Infect 80(1):58–62
Georgijević A, Cjukić-Ivancević S, Bujko M (2000) Bacterial vaginosis. Epidemiology and risk factors. Srp Arh Celok Lek 128(1–2):29–33
Schwebke JR, Desmond RA, Oh MK. Predictors of bacterial vaginosis in adolescent women who douche. Sex Transm Dis. 2004;31(7):433–6.
Brotman RM, Ghanem KG, Klebanoff MA, Taha TE, Scharfstein DO, Zenilman JM. The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol. 2008;198(6):628. e621-627
Thoma ME, Klebanoff MA, Rovner AJ, Nansel TR, Neggers Y, Andrews WW et al (2011) Bacterial vaginosis is associated with variation in dietary indices. J Nutr 141(9):1698–1704
Chaban B, Links MG, Jayaprakash TP, Wagner EC, Bourque DK, Lohn Z et al (2014) Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome 2:23
Xiao BB, Liao QP (2012) Analysis of diversity of vaginal microbiota in healthy Chinese women by using DNA-fngerprinting. Beijing Da Xue Xue Bao Yi Xue Ban 44(2):281–287
Jespers V, Menten J, Smet H, Poradosú S, Abdellati S, Verhelst R et al (2012) Quantifcation of bacterial species of the vaginal microbiome in diferent groups of women, using nucleic acid amplifcation tests. BMC Microbiol 12:83
Anukam KC, Osazuwa EO, Ahonkhai I, Reid G (2006) Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city Nigeria. Sex Transm Dis 33(1):59–62
Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL et al (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 108(Suppl 1):4680–4687
MacIntyre DA, Chandiramani M, Lee YS, Kindinger L, Smith A, Angelopoulos N, Lehne B, Arulkumaran S, Brown R, Teoh TG, et al. The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci Rep. 2015;5:8988.
Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014;21(5):450–8.
Kindinger LM, MacIntyre DA, Lee YS, Marchesi JR, Smith A, McDonald JA, Terzidou V, Cook JR, Lees C, Israfil-Bayli F, et al. Relationship between vaginal microbial dysbiosis, inflammation, and pregnancy outcomes in cervical cerclage. Sci Transl Med. 2016;8(350):350ra102.
Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, Galuppi M, Lamont RF, Chaemsaithong P, Miranda J, et al. The composition and stability of the vaginal microbiota of normal pregnant women
Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M (2009) Longitudinal analysis of the vaginal microfora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microfora and that L. gasseri and/ or L. iners are more conducive to the occurrence of abnormal vaginal microfora. BMC Microbiol. https://doi.org/10.1186/1471-2180-9-116
Brotman, R.M.; Shardell, M.D.; Gajer, P.; Tracy, J.K.; Zenilman, J.M.; Ravel, J.; Gravitt, P.E. Interplay Between the Temporal Dynamics of the Vaginal Microbiota and Human Papillomavirus Detection. J. Infect. Dis. 2014, 210, 1723–1733. http://doi.org/10.1093/infdis/jiu330
Duchi, S.; Onofrillo, C.; O’Connell, C.D.; Blanchard, R.; Augustine, C.; Quigley, A.F.; Kapsa, R.M.; Pivonka, P.; Wallace, G.; Di Bella, C.; et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillo-mavirus infection. Sci. Rep. 2017, 7, 5837. http://doi.org/10.1038/s41598-017-05699-x
Adebamowo, S.N.; Ma, B.; Zella, D.; Famooto, A.; Ravel, J.; Adebamowo, C. Mycoplasma hominis and mycoplasma genitalium in the vaginal microbiota and persistent high-risk human papillomavirus infection. Front. Public Health 2017, 5, 1–10. http://doi.org/10.3389/fpubh.2017.00140
Arokiyaraj, S.; Seo, S.S.; Kwon, M.; Lee, J.K.; Kim, M.K. Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: A longitudinal study. Sci. Rep. 2018, 8, 15479. http://doi.org/10.1038/s41598-018-33750-y
Drell T, Lillsaar T, Tummeleht L, Simm J, Aaspõllu A, Väin E et al (2013) Characterization of the vaginal micro-and mycobiome in asymptomatic reproductive-age Estonian women. PLoS ONE 8(1):e54379
Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol. 2013;209(6):505–23
van de Wijgert JH, Borgdorf H, Verhelst R, Crucitti T, Francis S, Verstraelen H et al (2014) The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS ONE 9(8):e105998
Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH et al (1995) Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The vaginal infections and prematurity study group. N Engl J Med 333(26):1737–1742
Petrova MI, van den Broek M, Balzarini J, Vanderleyden J, Lebeer S (2013) Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiol Rev 37(5):762–792
Barbone F, Austin H, Louv WC, Alexander WJ (1990) A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol 163(2):510–514
Koshiol, J.; Lindsay, L.; Pimenta, J.M.; Poole, C.; Jenkins, D.; Smith, J.S. Persistent human papillomavirus infection and cervical neoplasia: A systematic review and meta-analysis. Am. J. Epidemiol. 2008, 168, 123–137. http://doi.org/10.1093/aje/kwn036
Vedham, V.; Verma, M.; Mahabir, S. Early-life exposures to infectious agents and later cancer development. Cancer Med. 2015, 4, 1908–1922 http://doi.org/10.1002/cam4.538
Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. A 2- year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis. 2007; 195(11):1582–9
Bzhalava, D.; Eklund, C.; Dillner, J. International Standardization and Classification of Human Papillomavirus Types. Virology 2015, 476, 341–344 https://doi.org/10.1016/j.virol.2014.12.028
McLaughlin-Daurbin, M.E.; Münger, K. Oncogenic Activities of Human Papillomaviruses Margaret. Virus Res. 2009, 143, 195–208. https://doi.org/10.1016/j.virusres.2009.06.008
Castellsagué, X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol. Oncol. 2008, 110 (Suppl. S2), S4–S7 http://doi.org/10.1016/j.ygyno.2008.07.045
Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. http://doi.org/10.3322/caac.21492
Trottier, H.; Franco, E.L. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24 (Suppl. S1), S4–S15. http://doi.org/10.1016/j.vaccine.2005.09.054
Sreedevi, A.; Javed, R.; Dinesh, A. Epidemiology of cervical cancer with special focus on India. Int. J. Womens Health 2015, 7, 405–414.
Erickson, B.K.; Alvarez, R.D.; Huh, W.K. Human papillomavirus: What every provider should know. Am. J. Obstet. Gynecol. 2014, 208, 169–175. http://doi.org/10.1016/j.ajog.2012.09.007
Hariri, S.; Unger, E.; Sternberg, M.; Dunne, E.F.; Swan, D.; Patel, S.; Markowitz, L.E. Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003. J. Infect. Dis. 2011, 204, 566–573. http://doi.org/10.1093/infdis/jir341
Caruso, S.; Bruno, M.T.; Cianci, S.; Di Pasqua, S.; Minona, P.; Cianci, A. Sexual Behavior of Women With Diagnosed HPV. J. Sex Marital Ther. 2019, 45, 569–573. http://doi.org/10.1080/0092623X.2019.1586019
Audirac-Chalifour, A.; Torres-Poveda, K.; Bahena-Román, M.; Téllez-Sosa, J.; Martinez-Barnetche, J.; Cortina-Ceballos, B.; López-Estrada, G.; Delgado-Romero, K.; Burguete-García, A.I.; Cantú, D.; et al. Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study. PLoS ONE 2016, 11, e0153274. http://doi.org/10.1371/journal.pone.0153274
Pino, A.; Rapisarda, A.M.C.; Vitale, S.G.; Cianci, S.; Caggia, C.; Randazzo, C.L.; Cianci, A. A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis. Sci. Rep. 2021, 11, 2592. http://doi.org/10.1038/s41598-021-81931-z
Schiffman, M.; Castle, P.E. The Promise of Global Cervical-Cancer Prevention. N. Engl. J. Med. 2005, 353, 2101–2104. http://doi.org/10.1056/NEJMp058171
Joura, E.A.; Ault, K.A.; Bosch, F.X.; Brown, D.; Cuzick, J.; Ferris, D.; Garland, S.M.; Giuliano, A.R.; Hernandez-Avila, M.; Huh, W.; et al. Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease. Cancer Epidemiol. Biomarkers Prev. 2014, 23, 1997–2008. http://doi.org/10.1158/1055-9965.EPI-14-0410
Tommasino, M. The human papillomavirus family and its role in carcinogenesis. Semin. Cancer Biol. 2014, 26, 13–21. http://doi.org/10.1016/j.semcancer.2013.11.002
Chee, W.J.Y.; Chew, S.Y.; Than, L.T.L. Vaginal Microbiota and the Potential of Lactobacillus Derivatives in Maintaining Vaginal Health. Microb. Cell Fact. 2020, 19, 203. https://doi.org/10.1186/s12934-020-01464-4
Kaelin, E.A.; Skidmore, P.T.; Łaniewski, P.; Holland, L.A.; Chase, D.M.; Herbst-Kralovetz, M.M.; Lim, E.S. Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition. mSystems 2022, 7, e00064-22. https://doi.org/10.1128/msystems.00064-22
Sodhani, P.; Gupta, S.; Gupta, R.; Mehrotra, R. Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Is There an Association or Is Co-Existence Incidental? Asian Pac. J. Cancer Prev. 2017, 18, 1289–1292. https://doi.org/10.22034/APJCP.2017.18.5.1289
Lin, S.; Zhang, B.; Lin, Y.; Lin, Y.; Zuo, X. Dysbiosis of Cervical and Vaginal Microbiota Associated with Cervical Intraepithelial Neoplasia. Front. Cell. Infect. Microbiol. 2022, 12, 767693. https://doi.org/10.3389/fcimb.2022.767693
Xu, X.; Zhang, Y.; Yu, L.; Shi, X.; Min, M.; Xiong, L.; Pan, J.; Liu, P.; Wu, G.; Gao, G. A Cross-Sectional Analysis about Bacterial Vaginosis, High-Risk Human Papillomavirus Infection, and Cervical Intraepithelial Neoplasia in Chinese Women. Sci. Rep. 2022, 12, 6609. https://doi.org/10.1038/s41598-022-10532-1
Onderdonk, A.B.; Delaney, M.L.; Fichorova, R.N. The Human Microbiome during Bacterial Vaginosis. Clin. Microbiol. Rev. 2016, 29, 223–238. https://doi.org/10.1128/CMR.00075-15
Sun, N.; Ding, H.; Yu, H.; Ji, Y.; Xifang, X.; Pang, W.; Wang, X.; Zhang, Q.; Li, W. Comprehensive Characterization of Microbial Community in the Female Genital Tract of Reproductive-Aged Women in China. Front. Cell. Infect. Microbiol. 2021, 11, 649067. https://doi.org/10.3389/fcimb.2021.649067
Torcia, M.G. Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections. Int. J. Mol. Sci. 2019, 20, 266. https://doi.org/10.3390/ijms20020266
Łaniewski, P.; Barnes, D.; Goulder, A.; Cui, H.; Roe, D.J.; Chase, D.M.; Herbst-Kralovetz, M.M. Linking Cervicovaginal Immune Signatures, HPV and Microbiota Composition in Cervical Carcinogenesis in Non-Hispanic and Hispanic Women. Sci. Rep. 2018, 8, 7593. https://doi.org/10.1038/s41598-018-25879-7
Mitchell, C.; Marrazzo, J. Bacterial Vaginosis and the Cervicovaginal Immune Response. Am. J. Reprod. Immunol. 2014, 71, 555–563. https://doi.org/10.1111/aji.12264
Borgdorff, H.; Gautam, R.; Armstrong, S.D.; Xia, D.; Ndayisaba, G.F.; Van Teijlingen, N.H.; Geijtenbeek, T.B.H.; Wastling, J.M.; Van De Wijgert, J.H.H.M. Cervicovaginal Microbiome Dysbiosis Is Associated with Proteome Changes Related to Alterations of the Cervicovaginal Mucosal Barrier. Mucosal Immunol. 2016, 9, 621–633. https://doi.org/10.1038/mi.2015.86
Anahtar, M.N.; Byrne, E.H.; Doherty, K.E.; Bowman, B.A.; Yamamoto, H.S.; Soumillon, M.; Padavattan, N.; Ismail, N.; Moodley, A.; Sabatini, M.E.; et al. Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract. Immunity 2015, 42, 965–976. https://doi.org/10.1016/j.immuni.2015.04.019
Łaniewski, P.; Herbst-Kralovetz, M.M. Bacterial Vaginosis and Health-Associated Bacteria Modulate the Immunometabolic Landscape in 3D Model of Human Cervix. NPJ Biofilms Microbiomes 2021, 7, 88. https://doi.org/10.1038/s41522-021-00259-8
Łaniewski, P.; Barnes, D.; Goulder, A.; Cui, H.; Roe, D.J.; Chase, D.M.; Herbst-Kralovetz, M.M. Linking Cervicovaginal Immune Signatures, HPV and Microbiota Composition in Cervical Carcinogenesis in Non-Hispanic and Hispanic Women. Sci. Rep. 2018, 8, 7593. https://doi.org/10.1038/s41598-018-25879-7
Fan, Q.; Wu, Y.; Li, M.; An, F.; Yao, L.; Wang, M.; Wang, X.; Yuan, J.; Jiang, K.; Li, W.; et al. Lactobacillus Spp. Create a Protective Micro-Ecological Environment through Regulating the Core Fucosylation of Vaginal Epithelial Cells against Cervical Cancer. Cell Death Dis. 2021, 12, 1094. https://doi.org/10.1038/s41419-021-04388-y
Lee JE, Lee S, Lee H, Song YM, Lee K, Han MJ, Sung J, Ko G. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One. 2013;8(5):e63514.
Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, Gravitt PE. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210(11):1723–33
Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, Gravitt PE. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210(11):1723–33
Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4680–7.
Di Paola, M.; Sani, C.; Clemente, A.M.; Iossa, A.; Perissi, E.; Castronovo, G.; Tanturli, M.; Rivero, D.; Cozzolino, F.; Cavalieri, D.; et al. Characterization of Cervico-Vaginal Microbiota in Women Developing Persistent High-Risk Human Papillomavirus Infection. Sci. Rep. 2017, 7, 10200. https://doi.org/10.1038/s41598-017-09842-6
Lin, W.; Zhang, Q.; Chen, Y.; Dong, B.; Xue, H.; Lei, H.; Lu, Y.; Wei, X.; Sun, P. Changes of the Vaginal Microbiota in HPV Infection and Cervical Intraepithelial Neoplasia: A Cross-Sectional Analysis. Sci. Rep. 2022, 12, 2812. https://doi.org/10.1038/s41598-022-06731-5
Donmez, H.G.; Sahal, G.; Akgor, U.; Cagan, M.; Ozgul, N.; Beksac, M.S. The Relationship between the Presence of HPV Infection and Biofilm Formation in Cervicovaginal Smears. Infection 2020, 48, 735–740. https://doi.org/10.1007/s15010-020-01478-5
Qingqing, B.; Jie, Z.; Songben, Q.; Juan, C.; Lei, Z.; Mu, X. Cervicovaginal Microbiota Dysbiosis Correlates with HPV Persistent Infection. Microb. Pathog. 2021, 152, 104617. https://doi.org/10.1016/j.micpath.2020.104617
Lebeau, A.; Bruyere, D.; Roncarati, P.; Peixoto, P.; Hervouet, E.; Cobraiville, G.; Taminiau, B.; Masson, M.; Gallego, C.; Mazzucchelli, G.; et al. HPV Infection Alters Vaginal Microbiome through Down-Regulating Host Mucosal Innate Peptides Used by Lactobacilli as Amino Acid Sources. Nat. Commun. 2022, 13, 1076. https://doi.org/10.1038/s41467-022-28724-8
Report FAO/WHO. 2001. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria [Internet]. p. 1–29; [cited 2017 November 15]. Available from: http://www.fao.org/tempref/docrep/fao/meeting/009/ y6398e.pdf
Markowiak, P.; Slizewska, K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. ´ Nutrients 2017, 9, 1021. https://doi.org/10.3390/nu9091021
Pourmollaei, S.; Barzegari, A.; Farshbaf-Khalili, A.; Nouri, M.; Fattahi, A.; Shahnazi, M.; Dittrich, R. Anticancer Effect of Bacteria on Cervical Cancer: Molecular Aspects and Therapeutic Implications. Life Sci. 2020, 246, 117413. https://doi.org/10.1016/j.lfs.2020.117413
Verhoeven, V.; Renard, N.; Makar, A.; Van Royen, P.; Bogers, J.P.; Lardon, F.; Peeters, M.; Baay, M. Probiotics Enhance the Clearance of Human Papillomavirus-Related Cervical Lesions: A Prospective Controlled Pilot Study. Eur. J. Cancer Prev. 2013, 22, 46–51. https://doi.org/10.1097/CEJ.0b013e328355ed23
Cha, M.; Lee, D.; An, H.; Lee, S.; Shin, S.; Kwon, J.; Kim, K.; Ha, N. Antiviral Activity of Bifidobacterium Adolescentis SPM1005-A on Human Papillomavirus Type 16. BMC Med. 2012, 10, 72. https://doi.org/10.1186/1741-7015-10-72
Jahanshahi, M.; Maleki Dana, P.; Badehnoosh, B.; Asemi, Z.; Hallajzadeh, J.; Mansournia, M.A.; Yousefi, B.; Yousefi, B.; Moazzami, B.; Chaichian, S. Anti-Tumor Activities of Probiotics in Cervical Cancer. J. Ovarian Res. 2020, 13, 68. https://doi.org/10.1186/s13048-020-00668-x
Azad, M.A.K.; Sarker, M.; Wan, D. Immunomodulatory Effects of Probiotics on Cytokine Profiles. Biomed Res. Int. 2018, 2018, 8063647. https://doi.org/10.1155/2018/8063647
Sungur, T.; Aslim, B.; Karaaslan, C.; Aktas, B. Impact of Exopolysaccharides (EPSs) of Lactobacillus Gasseri Strains Isolated from Human Vagina on Cervical Tumor Cells (HeLa). Anaerobe 2017, 47, 137–144. https://doi.org/10.1016/j.anaerobe.2017.05.013
Pourmollaei, S.; Barzegari, A.; Farshbaf-Khalili, A.; Nouri, M.; Fattahi, A.; Shahnazi, M.; Dittrich, R. Anticancer Effect of Bacteria on Cervical Cancer: Molecular Aspects and Therapeutic Implications. Life Sci. 2020, 246, 117413. https://doi.org/10.1016/j.lfs.2020.117413
Van Baarlen, P.; Troost, F.; Van Der Meer, C.; Hooiveld, G.; Boekschoten, M.; Brummer, R.J.M.; Kleerebezem, M. Human Mucosal in Vivo Transcriptome Responses to Three Lactobacilli Indicate How Probiotics May Modulate Human Cellular Pathways. Proc. Natl. Acad. Sci. USA 2011, 108, 4562–4569. https://doi.org/10.1073/pnas.1000079107
van de Wijgert, J.H.H.M.; Verwijs, M.C. Lactobacilli-Containing Vaginal Probiotics to Cure or Prevent Bacterial or Fungal Vaginal Dysbiosis: A Systematic Review and Recommendations for Future Trial Designs. BJOG Int. J. Obstet. Gynaecol. 2020, 127, 287–299. https://doi.org/10.1111/1471-0528.15870
111. Tomusiak, A.; Strus, M.; Heczko, P.B.; Adamski, P.; Stefa ´nski, G.; Mikołajczyk-Cicho ´nska, A.; Suda-Szczurek, M. Efficacy and Safety of a Vaginal Medicinal Product Containing Three Strains of Probiotic Bacteria: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial. Drug Des. Dev. Ther. 2015, 9, 5345–5354. https://doi.org/10.2147/DDDT.S89214
Zhu, Y.; Zhang, S. Antibacterial Activity and Mechanism of Lacidophilin From Lactobacillus Pentosus Against Staphylococcus Aureus and Escherichia Coli. Front. Microbiol. 2020, 11, 582349. https://doi.org/10.3389/fmicb.2020.582349
Sun, Y.; Xu, J.; Zhou, H.; You, L.; Zhu, Y. Influence of Lacidophilin Vaginal Capsules plus Rh-IFN- α 2b on Efficacy, Vaginal Microecology, and Safety of Patients with HPV Infection. Evid.-Based Complement. Altern. Med. 2022, 2022, 3632053. https://doi.org/10.1155/2022/3632053
Rodriguez-Arrastia, M.; Martinez-Ortigosa, A.; Rueda-Ruzafa, L.; Ayora, A.F.; Ropero-Padilla, C. Probiotic Supplements on Oncology Patients’ Treatment-Related Side Effects: A Systematic Review of Randomized Controlled Trials. Int. J. Environ. Res. Public Health 2021, 18, 4265. https://doi.org/10.3390/ijerph18084265
Negi, D.; Singh, A.; Joshi, N.; Mishra, N. Cisplatin and Probiotic Biomass Loaded Pessaries for the Management of Cervical Cancer. Anticancer Agents Med. Chem. 2019, 20, 589–598. https://doi.org/10.2174/1871520619666191211110640
Andreyev, J. Gastrointestinal Complications of Pelvic Radiotherapy: Are They of Any Importance? Gut 2005, 54, 1051–1054. https://doi.org/10.1136/gut.2004.062596
119. Linn, Y.H.; Thu, K.K.; Win, N.H.H. Effect of Probiotics for the Prevention of Acute Radiation-Induced Diarrhoea Among Cervical Cancer Patients: A Randomized Double-Blind Placebo-Controlled Study. Probiotics Antimicrob. Proteins 2019, 11, 638–647. https://doi.org/10.1007/s12602-018-9408-9
120. Yockey, L.J.; Hussain, F.A.; Bergerat, A.; Reissis, A.; Worrall, D.; Xu, J.; Gomez, I.; Bloom, S.M.; Mafunda, N.A.; Kelly, J.; et al. Screening and Characterization of Vaginal Fluid Donations for Vaginal Microbiota Transplantation. Sci. Rep. 2022, 12, 17948. https://doi.org/10.1038/s41598-022-22873-y
121. Lev-Sagie, A.; Goldman-Wohl, D.; Cohen, Y.; Dori-Bachash, M.; Leshem, A.; Mor, U.; Strahilevitz, J.; Moses, A.E.; Shapiro, H.; Yagel, S.; et al. Vaginal Microbiome Transplantation in Women with Intractable Bacterial Vaginosis. Nat. Med. 2019, 25, 1500–1504. https://doi.org/10.1038/s41591-019-0600-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Patrycja Kostrzewa, Michał Kostrzewa, Maciej Sergiusz Anioł, Anna Palmerska, Andrzej Piela, Kinga Piela, Olga Katarzyna Przybyła, Anna Szurma, Rafał Szurma, Szymon Pacek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 226
Number of citations: 0
